Nava Blumenfeld

Title: Nava Blumenfeld: Innovator in Ubiquitin Carrier Enzymes

Introduction

Nava Blumenfeld is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of biochemistry, particularly in the study of ubiquitin carrier enzymes. Her innovative work has led to the development of methods that enhance our understanding of protein degradation and its implications in various biological processes.

Latest Patents

Nava Blumenfeld holds a patent for the "Ubiquitin carrier enzyme E2-F1, purification, production, and use." This patent discloses a method for isolating and purifying a novel species of E2 ubiquitin-carrier protein, designated E2-F1. The patent also details a method for preparing enzymatically active fragments of the E2-F1 enzyme. Furthermore, it describes the use of purified E2-F1 to produce antibodies, which can detect the presence of E2-F1 in biological samples and inhibit protein degradation. Additionally, the patent includes information on recombinant DNA molecules that code for E2-F1, as well as the use of recombinant hosts and vectors to produce E2-F1 protein.

Career Highlights

Nava Blumenfeld is affiliated with the Rappaport Family Institute for Research in the Medical Sciences, where she conducts her research. Her work has been instrumental in advancing the understanding of ubiquitin-mediated processes, which are crucial for cellular regulation and function.

Collaborations

Nava has collaborated with notable scientists in her field, including Aaron J. Ciechanover and Hedva Gonen. These collaborations have further enriched her research and contributed to the advancement of knowledge in the area of ubiquitin carrier enzymes.

Conclusion

Nava Blumenfeld's innovative research and patent contributions have significantly impacted the field of biochemistry. Her work continues to pave the way for advancements in understanding protein degradation and its biological significance.